Clinical Trial Update: CBD (Cannabidiol) Intraoral Application and TMD (Temporomandibular Disorders) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for CBD (cannabidiol) intraoral application in temporomandibular disorders, currently in Phase 2 and Phase 3, with co-listed conditions in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myofascial Pain
• Orofacial Pain
• Temporomandibular Disorder

Drugs mentioned

• CBD (cannabidiol) intraoral application (cannabidiol)

Snippet

Sponsor: Medical University of Silesia | Conditions: Temporomandibular Disorder, Myofascial Pain | Phase 2, Phase 3 | Status: UNKNOWN